Corporate Investigations

Our Corporate Investigations reporting identifies companies and industries which may be impacted by existing or new rules and regulations coming from the regulatory agencies or Congress. For individual companies, we identify specific business practices which may face legal or regulatory risk, while our industry-focused content examines new regulations which may materially impact an entire industry, in the process highlighting companies within that industry which may be most impacted by changes in regulation.

REQUEST A TRIAL

RECENT ARTICLES | EDITOR'S PICK

View all

Zynex: Company’s Accounting Practices Raise Red Flags, According to Accounting Experts

The accounting practices of Zynex (ZYXI), a manufacturer of electrotherapy devices for pain management, are raising red flags with finance experts who questioned how the company is accounting for adjustments, allowances, and nonpayment of the claims it submits to insurers. According to...

May 24, 2023 Read Now >
Congressional Committee, Regulators Question Cigna System that Lets Its Doctors Deny Claims without Reading Patient Files

This article is published in partnership with ProPublica. A key congressional committee asked insurance giant Cigna on Tuesday to provide corporate documents so that lawmakers can examine the company’s practice of denying health care claims without ever opening a patient file. House...

May 16, 2023 Read Now >
Zynex: Company Overbilling Federal TRICARE Program for Electrodes; Practice Mirrors 2018 DOJ False Claims Act Settlement

Zynex Medical (ZYXI), a manufacturer of electrotherapy devices for pain management, is overbilling TRICARE, the military health program for active-duty soldiers and their family members, for millions of dollars in unnecessary supplies for its devices, according to a Capitol Forum...

May 11, 2023 Read Now >